nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—CYP2C9—Vismodegib—skin cancer	0.111	0.198	CbGbCtD
Pranlukast—CYP3A4—Imiquimod—skin cancer	0.0933	0.166	CbGbCtD
Pranlukast—CYP3A4—Temozolomide—skin cancer	0.0933	0.166	CbGbCtD
Pranlukast—ABCC2—Docetaxel—skin cancer	0.0898	0.16	CbGbCtD
Pranlukast—RNASE3—nose—skin cancer	0.0835	0.328	CbGeAlD
Pranlukast—IL5—nose—skin cancer	0.0758	0.297	CbGeAlD
Pranlukast—CYP3A4—Vismodegib—skin cancer	0.0647	0.115	CbGbCtD
Pranlukast—CYP3A4—Vemurafenib—skin cancer	0.0511	0.0912	CbGbCtD
Pranlukast—CYP2C9—Fluorouracil—skin cancer	0.0395	0.0705	CbGbCtD
Pranlukast—CYP3A4—Docetaxel—skin cancer	0.0175	0.0313	CbGbCtD
Pranlukast—IL5—connective tissue—skin cancer	0.00874	0.0343	CbGeAlD
Pranlukast—IL5—epithelium—skin cancer	0.0083	0.0326	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—skin cancer	0.00704	0.0276	CbGeAlD
Pranlukast—MUC2—connective tissue—skin cancer	0.00672	0.0264	CbGeAlD
Pranlukast—IL5—lymphoid tissue—skin cancer	0.00639	0.0251	CbGeAlD
Pranlukast—MUC2—epithelium—skin cancer	0.00638	0.025	CbGeAlD
Pranlukast—NFKB1—nipple—skin cancer	0.0054	0.0212	CbGeAlD
Pranlukast—MUC2—female reproductive system—skin cancer	0.00474	0.0186	CbGeAlD
Pranlukast—MUC2—head—skin cancer	0.00396	0.0155	CbGeAlD
Pranlukast—NFKB1—connective tissue—skin cancer	0.00383	0.015	CbGeAlD
Pranlukast—IL5—lymph node—skin cancer	0.00361	0.0142	CbGeAlD
Pranlukast—NFKB1—mammalian vulva—skin cancer	0.00316	0.0124	CbGeAlD
Pranlukast—CYSLTR1—mammalian vulva—skin cancer	0.0031	0.0122	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—skin cancer	0.0028	0.011	CbGeAlD
Pranlukast—TNF—lymph node—skin cancer	0.00277	0.0109	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—skin cancer	0.00275	0.0108	CbGeAlD
Pranlukast—NFKB1—female reproductive system—skin cancer	0.0027	0.0106	CbGeAlD
Pranlukast—CYSLTR1—female reproductive system—skin cancer	0.00266	0.0104	CbGeAlD
Pranlukast—NFKB1—head—skin cancer	0.00226	0.00886	CbGeAlD
Pranlukast—CYSLTR1—head—skin cancer	0.00222	0.00871	CbGeAlD
Pranlukast—NFKB1—lymph node—skin cancer	0.00158	0.00621	CbGeAlD
Pranlukast—CYSLTR1—lymph node—skin cancer	0.00155	0.0061	CbGeAlD
Pranlukast—ABCC2—female reproductive system—skin cancer	0.00106	0.00417	CbGeAlD
Pranlukast—CYP2C9—female reproductive system—skin cancer	0.000707	0.00277	CbGeAlD
Pranlukast—ABCC2—lymph node—skin cancer	0.000621	0.00244	CbGeAlD
Pranlukast—CYP3A4—female reproductive system—skin cancer	0.000539	0.00212	CbGeAlD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—skin cancer	0.000339	0.00184	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GLI2—skin cancer	0.000332	0.0018	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000327	0.00177	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—KRAS—skin cancer	0.000326	0.00176	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CDKN2A—skin cancer	0.000323	0.00175	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CDK4—skin cancer	0.000322	0.00174	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—IL6—skin cancer	0.000322	0.00174	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—HRAS—skin cancer	0.000321	0.00174	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—KRAS—skin cancer	0.000318	0.00172	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—IL6—skin cancer	0.000317	0.00172	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MC1R—skin cancer	0.000317	0.00172	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTCH2—skin cancer	0.000314	0.0017	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GLI1—skin cancer	0.000312	0.00169	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—BRAF—skin cancer	0.000307	0.00166	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SUFU—skin cancer	0.000296	0.0016	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDK4—skin cancer	0.000293	0.00159	CbGpPWpGaD
Pranlukast—NFKB1—Fc-epsilon receptor I signaling in mast cells—HRAS—skin cancer	0.000291	0.00158	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—PTGS2—skin cancer	0.000291	0.00158	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000289	0.00157	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TP53—skin cancer	0.000289	0.00157	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000288	0.00156	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000287	0.00156	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—NRAS—skin cancer	0.000287	0.00155	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—IL6—skin cancer	0.000286	0.00155	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TP53—skin cancer	0.000286	0.00155	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—skin cancer	0.000285	0.00154	CbGpPWpGaD
Pranlukast—IL5—Immune System—FOXO4—skin cancer	0.000284	0.00154	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—skin cancer	0.000282	0.00153	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—BRAF—skin cancer	0.000282	0.00153	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—HRAS—skin cancer	0.00028	0.00152	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—PTGER4—skin cancer	0.000278	0.00151	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000278	0.00151	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—HRAS—skin cancer	0.000277	0.0015	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—SHH—skin cancer	0.000274	0.00148	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RASA1—skin cancer	0.000274	0.00148	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—HRAS—skin cancer	0.00027	0.00146	CbGpPWpGaD
Pranlukast—NFKB1—BCR signaling pathway—HRAS—skin cancer	0.00027	0.00146	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IL6—skin cancer	0.000262	0.00142	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PTCH1—skin cancer	0.00026	0.00141	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—SMO—skin cancer	0.00026	0.00141	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000257	0.00139	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PTGER4—skin cancer	0.000253	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—NRAS—skin cancer	0.000252	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—NRAS—skin cancer	0.00025	0.00136	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000249	0.00135	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—HRAS—skin cancer	0.000247	0.00134	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000247	0.00134	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—skin cancer	0.000245	0.00133	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IL6—skin cancer	0.000245	0.00133	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—HRAS—skin cancer	0.000245	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—skin cancer	0.00024	0.0013	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GLI2—skin cancer	0.000238	0.00129	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—skin cancer	0.000236	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—skin cancer	0.000236	0.00128	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—skin cancer	0.00023	0.00125	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MC1R—skin cancer	0.000227	0.00123	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SHH—skin cancer	0.000226	0.00122	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR7—skin cancer	0.000224	0.00122	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN2A—skin cancer	0.000224	0.00122	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RASA1—skin cancer	0.000224	0.00121	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GLI1—skin cancer	0.000224	0.00121	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDK4—skin cancer	0.000222	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—skin cancer	0.000221	0.0012	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000221	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL6—skin cancer	0.00022	0.00119	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000219	0.00119	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—NRAS—skin cancer	0.000218	0.00118	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—skin cancer	0.000218	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—KRAS—skin cancer	0.000217	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—KRAS—skin cancer	0.000215	0.00117	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BRAF—skin cancer	0.000215	0.00116	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMO—skin cancer	0.000214	0.00116	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTCH1—skin cancer	0.000214	0.00116	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 cascade initiated on plasma membrane—IL6—skin cancer	0.000214	0.00116	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—HRAS—skin cancer	0.000213	0.00116	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SUFU—skin cancer	0.000212	0.00115	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HRAS—skin cancer	0.000212	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	0.000212	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—HRAS—skin cancer	0.00021	0.00114	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RASA1—skin cancer	0.000209	0.00113	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—skin cancer	0.000208	0.00113	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTGER4—skin cancer	0.000208	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL6—skin cancer	0.000208	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	0.000208	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000205	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—skin cancer	0.000204	0.00111	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—skin cancer	0.000203	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—HRAS—skin cancer	0.000201	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—skin cancer	0.000201	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000201	0.00109	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—skin cancer	0.000199	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FOXO4—skin cancer	0.000198	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—skin cancer	0.000197	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—skin cancer	0.000191	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FOXO4—skin cancer	0.000191	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—skin cancer	0.000189	0.00103	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—skin cancer	0.000189	0.00102	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000188	0.00102	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000188	0.00102	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	0.000187	0.00101	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000185	0.001	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—HRAS—skin cancer	0.000184	0.000999	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—BRAF—skin cancer	0.000184	0.000997	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FOXO4—skin cancer	0.000184	0.000996	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—HRAS—skin cancer	0.000183	0.000992	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—skin cancer	0.000181	0.000978	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NRAS—skin cancer	0.00018	0.000977	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.00018	0.000974	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—skin cancer	0.00018	0.000973	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTCH2—skin cancer	0.000178	0.000964	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	0.000178	0.000964	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—NRAS—skin cancer	0.000177	0.000959	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—skin cancer	0.000176	0.000956	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—skin cancer	0.00017	0.000922	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	0.00017	0.00092	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2A—skin cancer	0.000169	0.000918	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000166	0.000899	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SHH—skin cancer	0.000162	0.000877	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RASA1—skin cancer	0.000161	0.000872	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	0.00016	0.000867	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—HRAS—skin cancer	0.00016	0.000865	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—skin cancer	0.000158	0.000858	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—NRAS—skin cancer	0.000157	0.000851	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000156	0.000847	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—KRAS—skin cancer	0.000155	0.000841	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTCH1—skin cancer	0.000153	0.000831	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMO—skin cancer	0.000153	0.000831	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	0.000153	0.000829	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—skin cancer	0.000153	0.000828	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—KRAS—skin cancer	0.000152	0.000825	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTGER4—skin cancer	0.000149	0.000809	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000147	0.000799	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—skin cancer	0.000146	0.000794	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	0.000146	0.000792	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000144	0.000781	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—skin cancer	0.000143	0.000772	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000141	0.000763	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00014	0.000759	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—skin cancer	0.000138	0.000747	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000137	0.000745	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—skin cancer	0.000137	0.000741	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—skin cancer	0.000135	0.000734	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KRAS—skin cancer	0.000135	0.000733	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NRAS—skin cancer	0.000135	0.000731	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GLI2—skin cancer	0.000135	0.000731	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CDK4—skin cancer	0.000134	0.000728	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000132	0.000716	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FOXO4—skin cancer	0.000132	0.000715	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—skin cancer	0.000132	0.000715	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—skin cancer	0.000132	0.000712	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	0.00013	0.000705	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MC1R—skin cancer	0.000129	0.000697	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GLI1—skin cancer	0.000127	0.000687	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—skin cancer	0.000125	0.000679	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—skin cancer	0.000125	0.000676	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	0.000124	0.000673	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TERT—skin cancer	0.000123	0.000665	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000122	0.000662	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SUFU—skin cancer	0.00012	0.000651	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	0.000119	0.000644	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000118	0.000637	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—KRAS—skin cancer	0.000116	0.000629	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—skin cancer	0.000116	0.000628	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NRAS—skin cancer	0.000116	0.000627	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FOXO4—skin cancer	0.000116	0.000626	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—skin cancer	0.000115	0.000623	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—skin cancer	0.000114	0.000619	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—skin cancer	0.00011	0.000596	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.00011	0.000595	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000105	0.000567	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NRAS—skin cancer	0.000103	0.000561	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—skin cancer	0.000103	0.000559	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CDK4—skin cancer	0.000102	0.000554	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000101	0.000548	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—skin cancer	0.0001	0.000543	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KRAS—skin cancer	9.95e-05	0.000539	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BRAF—skin cancer	9.73e-05	0.000527	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRAS—skin cancer	9.45e-05	0.000512	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—skin cancer	9.43e-05	0.000511	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	9.31e-05	0.000504	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SHH—skin cancer	9.17e-05	0.000497	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RASA1—skin cancer	9.11e-05	0.000493	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—KRAS—skin cancer	8.91e-05	0.000482	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TERT—skin cancer	8.81e-05	0.000478	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMO—skin cancer	8.69e-05	0.000471	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTCH1—skin cancer	8.69e-05	0.000471	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—skin cancer	8.63e-05	0.000468	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—skin cancer	8.61e-05	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—skin cancer	8.46e-05	0.000458	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTGER4—skin cancer	8.46e-05	0.000458	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—skin cancer	8.24e-05	0.000446	CbGpPWpGaD
Pranlukast—IL5—Immune System—KRAS—skin cancer	8.14e-05	0.000441	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—skin cancer	8.1e-05	0.000439	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—skin cancer	7.57e-05	0.00041	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FOXO4—skin cancer	7.47e-05	0.000405	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NRAS—skin cancer	7.47e-05	0.000405	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NRAS—skin cancer	7.43e-05	0.000402	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—skin cancer	7.25e-05	0.000393	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BRAF—skin cancer	6.98e-05	0.000378	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—skin cancer	6.92e-05	0.000375	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—skin cancer	6.62e-05	0.000359	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRAS—skin cancer	6.6e-05	0.000357	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KRAS—skin cancer	6.43e-05	0.000348	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—KRAS—skin cancer	6.39e-05	0.000346	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRAS—skin cancer	6.33e-05	0.000343	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLIN2—skin cancer	6.24e-05	0.000338	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRAS—skin cancer	6.11e-05	0.000331	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NRAS—skin cancer	5.69e-05	0.000308	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KRAS—skin cancer	5.68e-05	0.000308	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—skin cancer	5.46e-05	0.000296	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KRAS—skin cancer	5.45e-05	0.000295	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—skin cancer	5.43e-05	0.000294	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KRAS—skin cancer	5.26e-05	0.000285	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—skin cancer	5.23e-05	0.000283	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—skin cancer	5.2e-05	0.000282	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CSPG4—skin cancer	5.03e-05	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TERT—skin cancer	4.99e-05	0.00027	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KRAS—skin cancer	4.9e-05	0.000265	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—skin cancer	4.83e-05	0.000261	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—skin cancer	4.68e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—skin cancer	4.63e-05	0.000251	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—skin cancer	4.62e-05	0.00025	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—skin cancer	4.47e-05	0.000242	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRAS—skin cancer	4.39e-05	0.000238	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—skin cancer	4.28e-05	0.000232	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—skin cancer	4.16e-05	0.000226	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLIN2—skin cancer	4.12e-05	0.000223	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—skin cancer	3.98e-05	0.000216	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BRAF—skin cancer	3.95e-05	0.000214	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRAS—skin cancer	3.84e-05	0.000208	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KRAS—skin cancer	3.78e-05	0.000205	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ENO2—skin cancer	3.42e-05	0.000185	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—skin cancer	3.36e-05	0.000182	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CSPG4—skin cancer	3.32e-05	0.00018	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KRAS—skin cancer	3.31e-05	0.000179	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—skin cancer	3.21e-05	0.000174	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—skin cancer	3.07e-05	0.000166	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—skin cancer	2.81e-05	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—skin cancer	2.69e-05	0.000146	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.67e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRAS—skin cancer	2.48e-05	0.000135	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ENO2—skin cancer	2.26e-05	0.000122	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KRAS—skin cancer	2.14e-05	0.000116	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ERCC2—skin cancer	1.99e-05	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—skin cancer	1.9e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—skin cancer	1.82e-05	9.85e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—skin cancer	1.74e-05	9.42e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ERCC2—skin cancer	1.31e-05	7.1e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—skin cancer	1.19e-05	6.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—skin cancer	7.86e-06	4.26e-05	CbGpPWpGaD
